# A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

> **NCT03369808** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 360 (actual)

## Conditions studied

- H7N9 Influenza

## Interventions

- **BIOLOGICAL:** 7.5μg H7N9 Vaccine
- **BIOLOGICAL:** Phosphate Buffer Solution
- **BIOLOGICAL:** Aluminum Hydroxide Adjuvant
- **BIOLOGICAL:** 15μg H7N9 Vaccine
- **BIOLOGICAL:** 30μg H7N9 Vaccine

## Key facts

- **NCT ID:** NCT03369808
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-29
- **Primary completion:** 2018-08-29
- **Final completion:** 2019-11-15
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369808, "A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03369808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*